— · Biotechnology

ACADIA Pharmaceuticals Inc. (ACAD) Stock

$19.58 -0.36% —: ACAD Healthcare

Valuation

MetricValue
Price$19.58
Market Cap$3.35B
P/E Ratio8.87
P/B Ratio2.62
P/S Ratio3.00
EPS (TTM)$2.29
52-Week High$30.96
52-Week Low$19.45
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE32.39%
ROA21.83%
ROCE6.25%
Gross Margin9.79%
Operating Margin9.79%
Net Margin33.42%
Debt/Equity0.06
Current Ratio3.83

Annual Financials (USD)

Metric20212022202320242025
Revenue$484.0M$517.0M$726.0M$958.0M$1.1B
Operating Profit$-170.0M$-224.0M$-73.0M$231.0M$105.0M
Net Profit$-168.0M$-216.0M$-61.0M$226.0M$391.0M
EPS$-1.05$-1.34$-0.37$1.36$2.29
Op Margin-35.2%-43.2%-10.1%24.1%9.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$700.0M$588.0M$749.0M$1.2B$1.6B
Total Liabilities$159.0M$187.0M$317.0M$455.0M$337.0M
Cash$147.0M$115.0M$189.0M$320.0M$178.0M
Borrowings$64.0M$62.0M$57.0M$52.0M$52.0M

Latest News

Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026 Business Wire · Jul 15, 2026 An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors? Motley Fool · Jul 11, 2026 ACADIA Pharmaceuticals (ACAD) Names A New Chief People Officer, Is It Still Below Fair Value? Simply Wall St. · Jul 11, 2026 Is ACADIA Pharmaceuticals (ACAD) Still Undervalued After The Daybue Win? Simply Wall St. · Jul 10, 2026 How CHMP’s Positive Rett Syndrome Ruling on DAYBU Could Impact ACADIA Pharmaceuticals (ACAD) Investors Simply Wall St. · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-126.0M$-114.0M$17.0M$158.0M$110.0M
Investing Cash Flow$-72.0M$73.0M$-8.0M$-31.0M$-307.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-179.0M$-33.0M$74.0M$134.0M$-142.0M
Free Cash Flow$-127.0M$-114.0M$-23.0M$157.0M$105.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.13
EV / EBITDA26.74
FCF Yield5.10%
Quick Ratio3.30
Interest Coverage0.00
Return 1Y12.29%
Return 3Y3.92%
Return 5Y72.11%

Ownership

Insiders Held0.32%
Institutions Held98.91%
Institutions Float Held99.23%
Institutional HolderSharesReport Date
Baker Bros. Advisors, LP42,896,6902026-03-31
Blackrock Inc.21,550,9212026-03-31
Vanguard Portfolio Management LLC8,671,6452026-03-31
State Street Corporation8,332,7712026-03-31
RTW Investments LP7,144,5242026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANROAlto Neuroscience, Inc. $24.03 +2.17% -9.71 $843.31M 0.00%
AVXLAnavex Life Sciences Corp. $1.54 +0.65% -6.96 $142.71M 0.00%
AXSMAxsome Therapeutics, Inc. $170.08 -1.67% -49.17 $8.75B 0.00%
CTNMContineum Therapeutics, Inc. $13.18 +3.53% -7.58 $495.85M 0.00%
LBRXLB Pharmaceuticals Inc $34.61 +1.32% -12.45 $992.50M 0.00%

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. (ACAD) stock trades at $19.58 with a market capitalization of $3.35B. The stock is valued at a price-to-earnings (P/E) ratio of 8.87, price-to-book of 2.62, price-to-sales of 3.00. Over the past 52 weeks the stock has ranged between $19.45 and $30.96, and currently trades 36.8% below its 52-week high.

On profitability, ACADIA Pharmaceuticals Inc. generates a return on equity (ROE) of 32.39% — well above the market average, a sign of a high-quality business, return on capital employed of 6.25%, an operating margin of 9.79%, a net profit margin of 33.42%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides